Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: late night press release from PTSC?

It appears this PR is also our indication that the CDX technical review has been favorably completed.

This follows on the heels of a completed independent assessment conducted by a Fortune 1000 technology firm in which CDX scored very high marks in all significant categories including product stability, code quality, and overall design rigor.

I believe CDX is a quality product, however I am also anticipating that additional development regarding CDX will be forthcoming over the next several months along the lines of a newer and more "automated" version. The automation aspect has been a recurring theme in comments made by the company over the past year, and I believe this is a critical area for ease of implementation and use.

All in my opinion.

Cheers,

DG

Share
New Message
Please login to post a reply